reporting of carcinomas of the larynx and hypopharynxcpo-media.net › ecp › 2019 ›...
TRANSCRIPT
![Page 1: Reporting of carcinomas of the larynx and hypopharynxcpo-media.net › ECP › 2019 › Congress-Presentations › 55 › Zidar Nina.pdfhypopharynx • Not staging ... •favourable](https://reader034.vdocument.in/reader034/viewer/2022042405/5f1e6194776da34433137203/html5/thumbnails/1.jpg)
Reporting of carcinomas of the larynx and hypopharynx
dr. Nina Zidar
Institute of Pathology, Faculty of Medicine
University of Ljubljana
Slovenia
![Page 2: Reporting of carcinomas of the larynx and hypopharynxcpo-media.net › ECP › 2019 › Congress-Presentations › 55 › Zidar Nina.pdfhypopharynx • Not staging ... •favourable](https://reader034.vdocument.in/reader034/viewer/2022042405/5f1e6194776da34433137203/html5/thumbnails/2.jpg)
Guidelines by International Collaboration on Cancer reporting (ICCR)
http://www.iccr-cancer.org/datasets
Arch Pathol Lab Med 2019; 143: 432-8
![Page 3: Reporting of carcinomas of the larynx and hypopharynxcpo-media.net › ECP › 2019 › Congress-Presentations › 55 › Zidar Nina.pdfhypopharynx • Not staging ... •favourable](https://reader034.vdocument.in/reader034/viewer/2022042405/5f1e6194776da34433137203/html5/thumbnails/3.jpg)
Core (required) elements
![Page 4: Reporting of carcinomas of the larynx and hypopharynxcpo-media.net › ECP › 2019 › Congress-Presentations › 55 › Zidar Nina.pdfhypopharynx • Not staging ... •favourable](https://reader034.vdocument.in/reader034/viewer/2022042405/5f1e6194776da34433137203/html5/thumbnails/4.jpg)
• Operative procedure
• Specimen type and dimensions
• Tumour site
• Histologic tumour type and grade
• Tumour focality
• Tumour dimensions
• Extent of invasion
• Perineural invasion
• Lymphovascular invasion
• Margin status
• Pathologic staging (pTNM)
![Page 5: Reporting of carcinomas of the larynx and hypopharynxcpo-media.net › ECP › 2019 › Congress-Presentations › 55 › Zidar Nina.pdfhypopharynx • Not staging ... •favourable](https://reader034.vdocument.in/reader034/viewer/2022042405/5f1e6194776da34433137203/html5/thumbnails/5.jpg)
Operative procedure, type and dimensions of specimen
• Biopsy (incisional, excisional)
• Resection
• Other
• Dimensions of specimen
• Hypopharynx
• Larynx
- endolaryngeal excision
- transoral laser excision
- supraglottic laryngectomy
- supracricoid laryngectomy
- total laryngectomy
- vertical hemilaryngectomy
- partial laryngectomy
- other
![Page 6: Reporting of carcinomas of the larynx and hypopharynxcpo-media.net › ECP › 2019 › Congress-Presentations › 55 › Zidar Nina.pdfhypopharynx • Not staging ... •favourable](https://reader034.vdocument.in/reader034/viewer/2022042405/5f1e6194776da34433137203/html5/thumbnails/6.jpg)
Tumour site and subsite
• Site determines the use of staging (UICC, AJCC)
![Page 7: Reporting of carcinomas of the larynx and hypopharynxcpo-media.net › ECP › 2019 › Congress-Presentations › 55 › Zidar Nina.pdfhypopharynx • Not staging ... •favourable](https://reader034.vdocument.in/reader034/viewer/2022042405/5f1e6194776da34433137203/html5/thumbnails/7.jpg)
Tumour focality and dimensions
• Unifocal, multifocal
• Principal site of involvement should be recorded
• Maximal dimension (in mm)
• Key determinant for staging carcinoma of hypopharynx
• Not staging criteria for carcinoma of larynx
• 30% of tissue shrinkage after fixation
![Page 8: Reporting of carcinomas of the larynx and hypopharynxcpo-media.net › ECP › 2019 › Congress-Presentations › 55 › Zidar Nina.pdfhypopharynx • Not staging ... •favourable](https://reader034.vdocument.in/reader034/viewer/2022042405/5f1e6194776da34433137203/html5/thumbnails/8.jpg)
Histologic tumour type and grade
• SCC
• Neuroendocrine carcinoma
• Salivary carcinomas
• Grade 1, 2, 3
• Well, moderately and poorly differentiated
![Page 9: Reporting of carcinomas of the larynx and hypopharynxcpo-media.net › ECP › 2019 › Congress-Presentations › 55 › Zidar Nina.pdfhypopharynx • Not staging ... •favourable](https://reader034.vdocument.in/reader034/viewer/2022042405/5f1e6194776da34433137203/html5/thumbnails/9.jpg)
Squamous cell carcinoma
1. Conventional SCC
2. SCC subtypes
- Verrucous carcinoma
- Papillary SCC
- Spindle cell SCC
- Basaloid SCC
- Adenosquamous carcinoma
- Lymphoepithelial carcinoma
![Page 10: Reporting of carcinomas of the larynx and hypopharynxcpo-media.net › ECP › 2019 › Congress-Presentations › 55 › Zidar Nina.pdfhypopharynx • Not staging ... •favourable](https://reader034.vdocument.in/reader034/viewer/2022042405/5f1e6194776da34433137203/html5/thumbnails/10.jpg)
Verrucous carcinoma
• Well differentiated SCC with favourable prognosis
• Slow growth, destruction
• No metastatic potential
• High frequency of initialmisdiagnosis
• Etiology similar to conventionalSCC
• Not related to HPV infection
![Page 11: Reporting of carcinomas of the larynx and hypopharynxcpo-media.net › ECP › 2019 › Congress-Presentations › 55 › Zidar Nina.pdfhypopharynx • Not staging ... •favourable](https://reader034.vdocument.in/reader034/viewer/2022042405/5f1e6194776da34433137203/html5/thumbnails/11.jpg)
Verrucous carcinoma
![Page 12: Reporting of carcinomas of the larynx and hypopharynxcpo-media.net › ECP › 2019 › Congress-Presentations › 55 › Zidar Nina.pdfhypopharynx • Not staging ... •favourable](https://reader034.vdocument.in/reader034/viewer/2022042405/5f1e6194776da34433137203/html5/thumbnails/12.jpg)
Hybrid carcinoma
• Verrucous carcinoma withfoci of conventional SCC
• Metastatic potential
• Must be treated as conventional SCC
![Page 13: Reporting of carcinomas of the larynx and hypopharynxcpo-media.net › ECP › 2019 › Congress-Presentations › 55 › Zidar Nina.pdfhypopharynx • Not staging ... •favourable](https://reader034.vdocument.in/reader034/viewer/2022042405/5f1e6194776da34433137203/html5/thumbnails/13.jpg)
Spindle cell carcinoma
• Biphasic tumor: conventionalSCC and malignant spindlecells
• Sarcomatoid carcinoma, carcinosarcoma
• Neoplastic epitheloid cellschange to spindle cells
• Pathogenesis: epithelial-mesenchymal transition
• Etiology: radiation
![Page 14: Reporting of carcinomas of the larynx and hypopharynxcpo-media.net › ECP › 2019 › Congress-Presentations › 55 › Zidar Nina.pdfhypopharynx • Not staging ... •favourable](https://reader034.vdocument.in/reader034/viewer/2022042405/5f1e6194776da34433137203/html5/thumbnails/14.jpg)
Spindle cell carcinoma
cytokeratin
vimentin
![Page 15: Reporting of carcinomas of the larynx and hypopharynxcpo-media.net › ECP › 2019 › Congress-Presentations › 55 › Zidar Nina.pdfhypopharynx • Not staging ... •favourable](https://reader034.vdocument.in/reader034/viewer/2022042405/5f1e6194776da34433137203/html5/thumbnails/15.jpg)
• 341 patients with spindle cell carcinoma, compared to 67 882 conventional SCC: worse prognosis in spindlecell carcinoma
• favourable prognosis: polypoid tumors, no history ofirradiation
![Page 16: Reporting of carcinomas of the larynx and hypopharynxcpo-media.net › ECP › 2019 › Congress-Presentations › 55 › Zidar Nina.pdfhypopharynx • Not staging ... •favourable](https://reader034.vdocument.in/reader034/viewer/2022042405/5f1e6194776da34433137203/html5/thumbnails/16.jpg)
Papillary squamous cell carcinoma
• Exophytic, papillary growthpattern and good prognosis
• Larynx: HPV neg.
• Recurrences are frequent(38%)
• Friable and soft, may extendover a broad surface area
• Difficult to demonstratestromal invasion
![Page 17: Reporting of carcinomas of the larynx and hypopharynxcpo-media.net › ECP › 2019 › Congress-Presentations › 55 › Zidar Nina.pdfhypopharynx • Not staging ... •favourable](https://reader034.vdocument.in/reader034/viewer/2022042405/5f1e6194776da34433137203/html5/thumbnails/17.jpg)
Papillary squamous cell carcinoma
![Page 18: Reporting of carcinomas of the larynx and hypopharynxcpo-media.net › ECP › 2019 › Congress-Presentations › 55 › Zidar Nina.pdfhypopharynx • Not staging ... •favourable](https://reader034.vdocument.in/reader034/viewer/2022042405/5f1e6194776da34433137203/html5/thumbnails/18.jpg)
Papillary squamous cell carcinoma
![Page 19: Reporting of carcinomas of the larynx and hypopharynxcpo-media.net › ECP › 2019 › Congress-Presentations › 55 › Zidar Nina.pdfhypopharynx • Not staging ... •favourable](https://reader034.vdocument.in/reader034/viewer/2022042405/5f1e6194776da34433137203/html5/thumbnails/19.jpg)
Basaloid squamous cell carcinoma
• Biphasic tumor: basaloidcells and SCC
• Aggressive, high grade SCC variant
• No characteristic grossappearance
• DD: HPV pos. carcinoma, neuroendocrine ca
• p16, synaptophysin, chromogranin
![Page 20: Reporting of carcinomas of the larynx and hypopharynxcpo-media.net › ECP › 2019 › Congress-Presentations › 55 › Zidar Nina.pdfhypopharynx • Not staging ... •favourable](https://reader034.vdocument.in/reader034/viewer/2022042405/5f1e6194776da34433137203/html5/thumbnails/20.jpg)
Basaloid squamous cell carcinoma
![Page 21: Reporting of carcinomas of the larynx and hypopharynxcpo-media.net › ECP › 2019 › Congress-Presentations › 55 › Zidar Nina.pdfhypopharynx • Not staging ... •favourable](https://reader034.vdocument.in/reader034/viewer/2022042405/5f1e6194776da34433137203/html5/thumbnails/21.jpg)
• 145 patients with basaloid SCC and 20 866 patients withconventional SCC
• poorer disease-specific survival in basaloid SCC
![Page 22: Reporting of carcinomas of the larynx and hypopharynxcpo-media.net › ECP › 2019 › Congress-Presentations › 55 › Zidar Nina.pdfhypopharynx • Not staging ... •favourable](https://reader034.vdocument.in/reader034/viewer/2022042405/5f1e6194776da34433137203/html5/thumbnails/22.jpg)
Adenosquamous carcinoma
• Two components: SCC (in situ or invasive) and adenocarcinoma
• Both components separated
• Not intermingled as in muco-epidermoid ca
• Aggressive clinical courseand poor prognosis
![Page 23: Reporting of carcinomas of the larynx and hypopharynxcpo-media.net › ECP › 2019 › Congress-Presentations › 55 › Zidar Nina.pdfhypopharynx • Not staging ... •favourable](https://reader034.vdocument.in/reader034/viewer/2022042405/5f1e6194776da34433137203/html5/thumbnails/23.jpg)
Lymphoepithelial carcinoma
• Poorly differentiated ca withlymphoplasmacytic stromalinfiltration
• Synonym: undifferentiatedcarcinoma of the nasopharyngeal type
• Usually HPV- and EBV-
• Aggressive, with regionallymph node and distantmetastases
![Page 24: Reporting of carcinomas of the larynx and hypopharynxcpo-media.net › ECP › 2019 › Congress-Presentations › 55 › Zidar Nina.pdfhypopharynx • Not staging ... •favourable](https://reader034.vdocument.in/reader034/viewer/2022042405/5f1e6194776da34433137203/html5/thumbnails/24.jpg)
Extent of invasion
• Involves mucosa
• Involves paraglotticspace
• Involves pre-epiglotticspace
• Partial thicknessinvasion of cartilage
• Full thickness invasionof cartilage
![Page 25: Reporting of carcinomas of the larynx and hypopharynxcpo-media.net › ECP › 2019 › Congress-Presentations › 55 › Zidar Nina.pdfhypopharynx • Not staging ... •favourable](https://reader034.vdocument.in/reader034/viewer/2022042405/5f1e6194776da34433137203/html5/thumbnails/25.jpg)
Perineural invasion
• Tumour cells within any of the three layers of the nerve sheath
• At least 1/3 of circumference
• Enables spread beyond the extent of local invasion
• Locoregional recurrence, decreased survival
![Page 26: Reporting of carcinomas of the larynx and hypopharynxcpo-media.net › ECP › 2019 › Congress-Presentations › 55 › Zidar Nina.pdfhypopharynx • Not staging ... •favourable](https://reader034.vdocument.in/reader034/viewer/2022042405/5f1e6194776da34433137203/html5/thumbnails/26.jpg)
Lymphovascular invasion
• Presence of tumour cells within an endothelial-lined space
• Lymphatic vessels, capillaries, veins
• Not necessary
• Weak predictor of nodal and distal metastases
• Should not be considered synonymous with metastasis
• Tumour cells in the lymphatic system and circulation can be destroyed
![Page 27: Reporting of carcinomas of the larynx and hypopharynxcpo-media.net › ECP › 2019 › Congress-Presentations › 55 › Zidar Nina.pdfhypopharynx • Not staging ... •favourable](https://reader034.vdocument.in/reader034/viewer/2022042405/5f1e6194776da34433137203/html5/thumbnails/27.jpg)
podoplanin
![Page 28: Reporting of carcinomas of the larynx and hypopharynxcpo-media.net › ECP › 2019 › Congress-Presentations › 55 › Zidar Nina.pdfhypopharynx • Not staging ... •favourable](https://reader034.vdocument.in/reader034/viewer/2022042405/5f1e6194776da34433137203/html5/thumbnails/28.jpg)
Margin status
• Clear margins = no invasive or in situ carcinoma
• Adequate margins = how much healthy tissue around the tumour must be removed
• Between 3 and 5 mm
• In laser excision of glottic cancer, even 1 mm may be adequate
• Report the distance from invasive/in situ carcinoma to the closest margin
![Page 29: Reporting of carcinomas of the larynx and hypopharynxcpo-media.net › ECP › 2019 › Congress-Presentations › 55 › Zidar Nina.pdfhypopharynx • Not staging ... •favourable](https://reader034.vdocument.in/reader034/viewer/2022042405/5f1e6194776da34433137203/html5/thumbnails/29.jpg)
Pathologic staging (pTNM)
![Page 30: Reporting of carcinomas of the larynx and hypopharynxcpo-media.net › ECP › 2019 › Congress-Presentations › 55 › Zidar Nina.pdfhypopharynx • Not staging ... •favourable](https://reader034.vdocument.in/reader034/viewer/2022042405/5f1e6194776da34433137203/html5/thumbnails/30.jpg)
Pathologic staging (pTNM)
• T: extent of tumour and infiltration of surrounding structures and organs
• N: nodal status - number of metastatic nodes, their location and size, and presence of extranodalextension
• M: presence of distant metastases
• UICC, AJCC
• Clinical + pathologic information
![Page 31: Reporting of carcinomas of the larynx and hypopharynxcpo-media.net › ECP › 2019 › Congress-Presentations › 55 › Zidar Nina.pdfhypopharynx • Not staging ... •favourable](https://reader034.vdocument.in/reader034/viewer/2022042405/5f1e6194776da34433137203/html5/thumbnails/31.jpg)
Noncore (recommended) elements
![Page 32: Reporting of carcinomas of the larynx and hypopharynxcpo-media.net › ECP › 2019 › Congress-Presentations › 55 › Zidar Nina.pdfhypopharynx • Not staging ... •favourable](https://reader034.vdocument.in/reader034/viewer/2022042405/5f1e6194776da34433137203/html5/thumbnails/32.jpg)
• Neoadjuvant therapy
• Tumour thickness
• Pattern of invasive front
• Coexistent pathology
• Ancillary studies
![Page 33: Reporting of carcinomas of the larynx and hypopharynxcpo-media.net › ECP › 2019 › Congress-Presentations › 55 › Zidar Nina.pdfhypopharynx • Not staging ... •favourable](https://reader034.vdocument.in/reader034/viewer/2022042405/5f1e6194776da34433137203/html5/thumbnails/33.jpg)
Neoadjuvant therapy
• Essential for correct interpretation of pathologic findings
• Presence and extent of changes (% of the tumour volume) related to previous treatment (e.g., necrosis, fibrosis)
• ypTNM
![Page 34: Reporting of carcinomas of the larynx and hypopharynxcpo-media.net › ECP › 2019 › Congress-Presentations › 55 › Zidar Nina.pdfhypopharynx • Not staging ... •favourable](https://reader034.vdocument.in/reader034/viewer/2022042405/5f1e6194776da34433137203/html5/thumbnails/34.jpg)
Pattern of invasive front
Expansive (cohesive) Infiltrative (noncohesive)
Pattern of growth at invasive front is not core data as there is insufficient evidence of their prognostic value for carcinoma of the larynx and hypopharynx.
![Page 35: Reporting of carcinomas of the larynx and hypopharynxcpo-media.net › ECP › 2019 › Congress-Presentations › 55 › Zidar Nina.pdfhypopharynx • Not staging ... •favourable](https://reader034.vdocument.in/reader034/viewer/2022042405/5f1e6194776da34433137203/html5/thumbnails/35.jpg)
Ancillary studies Coexistent pathology
• Immunohistochemistry
• p16 or HPV test not obligatory
• Flow cytometry
• Molecular genetics
• Infection, necrotizing sialometaplasia, dysplasia
• Thyroid pathology, lymphoma
![Page 36: Reporting of carcinomas of the larynx and hypopharynxcpo-media.net › ECP › 2019 › Congress-Presentations › 55 › Zidar Nina.pdfhypopharynx • Not staging ... •favourable](https://reader034.vdocument.in/reader034/viewer/2022042405/5f1e6194776da34433137203/html5/thumbnails/36.jpg)
Coexistent pathology
Thyroid carcinoma Lymphoma
![Page 37: Reporting of carcinomas of the larynx and hypopharynxcpo-media.net › ECP › 2019 › Congress-Presentations › 55 › Zidar Nina.pdfhypopharynx • Not staging ... •favourable](https://reader034.vdocument.in/reader034/viewer/2022042405/5f1e6194776da34433137203/html5/thumbnails/37.jpg)
Conclusions
• Use ICCR guidelines and data sets.
• Larynx anatomy is complex.
• Clinical information is needed forstaging.
• Extranodal extension is included in the new pTNM.
• Molecular genetics, new histologicprognostic markers, targeted therapy ???
![Page 38: Reporting of carcinomas of the larynx and hypopharynxcpo-media.net › ECP › 2019 › Congress-Presentations › 55 › Zidar Nina.pdfhypopharynx • Not staging ... •favourable](https://reader034.vdocument.in/reader034/viewer/2022042405/5f1e6194776da34433137203/html5/thumbnails/38.jpg)
Thank you for your attention!
Svečinske gorice, Slovenija